AxoGen, Inc. (AXGN)
USD 17.04
(-3.67%)
USD 17.04
(-3.67%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 149.33 Million USD | 3.6% |
| 2022 | 144.14 Million USD | 11.01% |
| 2021 | 129.84 Million USD | 14.0% |
| 2020 | 113.9 Million USD | -5.69% |
| 2019 | 120.76 Million USD | 31.97% |
| 2018 | 91.51 Million USD | 54.93% |
| 2017 | 59.06 Million USD | 38.1% |
| 2016 | 42.77 Million USD | 34.71% |
| 2015 | 31.74 Million USD | 36.99% |
| 2014 | 23.17 Million USD | 28.05% |
| 2013 | 18.09 Million USD | 33.76% |
| 2012 | 13.53 Million USD | 44.08% |
| 2011 | 9.39 Million USD | 384.16% |
| 2010 | 1.93 Million USD | -78.34% |
| 2009 | 8.95 Million USD | 692.88% |
| 2008 | 1.12 Million USD | 25.45% |
| 2007 | 900.35 Thousand USD | 71.81% |
| 2006 | 524.03 Thousand USD | -31.93% |
| 2005 | 769.87 Thousand USD | -35.28% |
| 2004 | 1.18 Million USD | -60.17% |
| 2003 | 2.98 Million USD | -27.71% |
| 2002 | 4.13 Million USD | -51.02% |
| 2001 | 8.43 Million USD | -5.44% |
| 2000 | 8.91 Million USD | 31.17% |
| 1999 | 6.8 Million USD | 38.78% |
| 1998 | 4.9 Million USD | -7.55% |
| 1997 | 5.3 Million USD | -20.9% |
| 1996 | 6.7 Million USD | 1.52% |
| 1995 | 6.6 Million USD | 73.68% |
| 1994 | 3.8 Million USD | 18.75% |
| 1993 | 3.2 Million USD | 33.33% |
| 1992 | 2.4 Million USD | 9.09% |
| 1991 | 2.2 Million USD | -8.33% |
| 1990 | 2.4 Million USD | 0.0% |
| 1989 | 2.4 Million USD | 9.09% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 35.77 Million USD | -3.78% |
| 2024 Q1 | 37.18 Million USD | 0.6% |
| 2023 Q1 | 37.29 Million USD | 4.67% |
| 2023 Q2 | 37.82 Million USD | 1.43% |
| 2023 Q3 | 37.25 Million USD | -1.52% |
| 2023 FY | 149.33 Million USD | 3.6% |
| 2023 Q4 | 36.95 Million USD | -0.79% |
| 2022 Q3 | 35.63 Million USD | -1.26% |
| 2022 Q4 | 35.63 Million USD | -0.02% |
| 2022 FY | 144.14 Million USD | 11.01% |
| 2022 Q1 | 36.78 Million USD | 16.91% |
| 2022 Q2 | 36.09 Million USD | -1.87% |
| 2021 Q4 | 31.46 Million USD | -3.65% |
| 2021 Q2 | 33.64 Million USD | 4.85% |
| 2021 Q1 | 32.08 Million USD | -0.99% |
| 2021 Q3 | 32.65 Million USD | -2.94% |
| 2021 FY | 129.84 Million USD | 14.0% |
| 2020 Q1 | 27.95 Million USD | -8.94% |
| 2020 FY | 113.9 Million USD | -5.69% |
| 2020 Q2 | 24.76 Million USD | -11.41% |
| 2020 Q3 | 28.77 Million USD | 16.2% |
| 2020 Q4 | 32.4 Million USD | 12.61% |
| 2019 Q3 | 30.16 Million USD | 0.12% |
| 2019 Q1 | 29.77 Million USD | 16.11% |
| 2019 Q2 | 30.12 Million USD | 1.19% |
| 2019 FY | 120.76 Million USD | 31.97% |
| 2019 Q4 | 30.7 Million USD | 1.77% |
| 2018 Q2 | 22.29 Million USD | 14.11% |
| 2018 Q1 | 19.53 Million USD | 20.89% |
| 2018 Q3 | 24.03 Million USD | 7.78% |
| 2018 FY | 91.51 Million USD | 54.93% |
| 2018 Q4 | 25.64 Million USD | 6.71% |
| 2017 Q4 | 16.16 Million USD | 7.47% |
| 2017 FY | 59.06 Million USD | 38.1% |
| 2017 Q2 | 14.33 Million USD | 5.99% |
| 2017 Q3 | 15.04 Million USD | 4.91% |
| 2017 Q1 | 13.52 Million USD | 9.98% |
| 2016 FY | 42.77 Million USD | 34.71% |
| 2016 Q4 | 12.29 Million USD | 15.05% |
| 2016 Q2 | 10.45 Million USD | 12.05% |
| 2016 Q3 | 10.68 Million USD | 2.26% |
| 2016 Q1 | 9.32 Million USD | 3.13% |
| 2015 Q3 | 8.66 Million USD | 15.01% |
| 2015 Q1 | 6.51 Million USD | -0.51% |
| 2015 FY | 31.74 Million USD | 36.99% |
| 2015 Q4 | 9.04 Million USD | 4.44% |
| 2015 Q2 | 7.53 Million USD | 15.64% |
| 2014 Q2 | 5.62 Million USD | 3.61% |
| 2014 FY | 23.17 Million USD | 28.05% |
| 2014 Q1 | 5.42 Million USD | 4.67% |
| 2014 Q3 | 5.57 Million USD | -0.82% |
| 2014 Q4 | 6.54 Million USD | 17.35% |
| 2013 FY | 18.09 Million USD | 33.76% |
| 2013 Q4 | 5.18 Million USD | 13.13% |
| 2013 Q3 | 4.58 Million USD | 3.64% |
| 2013 Q2 | 4.42 Million USD | 13.24% |
| 2013 Q1 | 3.9 Million USD | 2.87% |
| 2012 Q4 | 3.79 Million USD | 9.07% |
| 2012 Q3 | 3.48 Million USD | 12.4% |
| 2012 Q2 | 3.09 Million USD | -1.84% |
| 2012 Q1 | 3.15 Million USD | 11.99% |
| 2012 FY | 13.53 Million USD | 44.08% |
| 2011 Q4 | 2.81 Million USD | 6.86% |
| 2011 FY | 9.39 Million USD | 384.16% |
| 2011 Q1 | 2.13 Million USD | 279.37% |
| 2011 Q2 | 1.73 Million USD | -19.04% |
| 2011 Q3 | 2.63 Million USD | 52.34% |
| 2010 FY | 1.93 Million USD | -78.34% |
| 2010 Q4 | 563.56 Thousand USD | -11.93% |
| 2010 Q1 | 394.47 Thousand USD | -95.16% |
| 2010 Q2 | 341.87 Thousand USD | -13.33% |
| 2010 Q3 | 639.87 Thousand USD | 87.17% |
| 2009 FY | 8.95 Million USD | 692.88% |
| 2009 Q1 | 177.09 Thousand USD | 14.03% |
| 2009 Q2 | 471.48 Thousand USD | 166.23% |
| 2009 Q3 | 155.22 Thousand USD | -67.08% |
| 2009 Q4 | 8.15 Million USD | 5151.73% |
| 2008 Q4 | 155.3 Thousand USD | -74.11% |
| 2008 Q2 | 186.41 Thousand USD | -0.8% |
| 2008 Q1 | 187.91 Thousand USD | 44.2% |
| 2008 FY | 1.12 Million USD | 25.45% |
| 2008 Q3 | 599.86 Thousand USD | 221.79% |
| 2007 Q4 | 130.3 Thousand USD | -72.23% |
| 2007 Q3 | 469.28 Thousand USD | 173.54% |
| 2007 Q2 | 171.55 Thousand USD | 32.78% |
| 2007 Q1 | 129.2 Thousand USD | -27.34% |
| 2007 FY | 900.35 Thousand USD | 71.81% |
| 2006 FY | 524.03 Thousand USD | -31.93% |
| 2006 Q4 | 177.81 Thousand USD | 84.63% |
| 2006 Q3 | 96.3 Thousand USD | -9.2% |
| 2006 Q2 | 106.06 Thousand USD | -26.27% |
| 2006 Q1 | 143.85 Thousand USD | 23.39% |
| 2005 Q3 | 87.85 Thousand USD | 0.0% |
| 2005 FY | 769.87 Thousand USD | -35.28% |
| 2005 Q4 | 116.58 Thousand USD | 32.71% |
| 2005 Q2 | - USD | -100.0% |
| 2005 Q1 | 459.6 Thousand USD | -48.03% |
| 2004 Q1 | 666.08 Thousand USD | -6.22% |
| 2004 Q3 | 141.13 Thousand USD | -62.04% |
| 2004 Q4 | 884.29 Thousand USD | 526.55% |
| 2004 Q2 | 371.76 Thousand USD | -44.19% |
| 2004 FY | 1.18 Million USD | -60.17% |
| 2003 Q3 | 676.24 Thousand USD | -17.36% |
| 2003 Q4 | 710.28 Thousand USD | 5.03% |
| 2003 Q1 | 781.97 Thousand USD | 4.73% |
| 2003 FY | 2.98 Million USD | -27.71% |
| 2003 Q2 | 818.27 Thousand USD | 4.64% |
| 2002 Q2 | 1.19 Million USD | -4.66% |
| 2002 FY | 4.13 Million USD | -51.02% |
| 2002 Q3 | 930.19 Thousand USD | -22.35% |
| 2002 Q4 | 746.68 Thousand USD | -19.73% |
| 2002 Q1 | 1.25 Million USD | 0.0% |
| 2001 Q3 | 2.13 Million USD | -2.97% |
| 2001 FY | 8.43 Million USD | -5.44% |
| 2001 Q1 | 2.03 Million USD | -5.76% |
| 2001 Q2 | 2.2 Million USD | 7.96% |
| 2000 FY | 8.91 Million USD | 31.17% |
| 2000 Q2 | 2.63 Million USD | 11.91% |
| 2000 Q1 | 2.35 Million USD | 7.11% |
| 2000 Q4 | 2.16 Million USD | -8.41% |
| 2000 Q3 | 2.36 Million USD | -10.45% |
| 1999 Q1 | 1.6 Million USD | -11.11% |
| 1999 Q2 | 1.8 Million USD | 12.5% |
| 1999 Q3 | 1.8 Million USD | 0.0% |
| 1999 Q4 | 2.2 Million USD | 22.22% |
| 1999 FY | 6.8 Million USD | 38.78% |
| 1998 FY | 4.9 Million USD | -7.55% |
| 1998 Q3 | 1.4 Million USD | 16.67% |
| 1998 Q4 | 1.8 Million USD | 28.57% |
| 1998 Q2 | 1.2 Million USD | -7.69% |
| 1998 Q1 | 1.3 Million USD | 8.33% |
| 1997 Q1 | 1.3 Million USD | -13.33% |
| 1997 FY | 5.3 Million USD | -20.9% |
| 1997 Q4 | 1.2 Million USD | 0.0% |
| 1997 Q3 | 1.2 Million USD | 0.0% |
| 1997 Q2 | 1.2 Million USD | -7.69% |
| 1996 FY | 6.7 Million USD | 1.52% |
| 1996 Q3 | 1.4 Million USD | 16.67% |
| 1996 Q4 | 1.5 Million USD | 7.14% |
| 1996 Q2 | 1.2 Million USD | -25.0% |
| 1996 Q1 | 1.6 Million USD | -27.27% |
| 1995 Q3 | 1.7 Million USD | -15.0% |
| 1995 Q1 | 1.6 Million USD | 6.67% |
| 1995 FY | 6.6 Million USD | 73.68% |
| 1995 Q4 | 2.2 Million USD | 29.41% |
| 1995 Q2 | 2 Million USD | 25.0% |
| 1994 Q1 | 800 Thousand USD | 0.0% |
| 1994 Q3 | 1.5 Million USD | 25.0% |
| 1994 FY | 3.8 Million USD | 18.75% |
| 1994 Q4 | 1.5 Million USD | 0.0% |
| 1994 Q2 | 1.2 Million USD | 50.0% |
| 1993 FY | 3.2 Million USD | 33.33% |
| 1993 Q3 | 900 Thousand USD | 12.5% |
| 1993 Q4 | 800 Thousand USD | -11.11% |
| 1993 Q1 | 800 Thousand USD | 0.0% |
| 1993 Q2 | 800 Thousand USD | 0.0% |
| 1992 Q2 | 500 Thousand USD | -28.57% |
| 1992 Q4 | 800 Thousand USD | 0.0% |
| 1992 Q3 | 800 Thousand USD | 60.0% |
| 1992 Q1 | 700 Thousand USD | 16.67% |
| 1992 FY | 2.4 Million USD | 9.09% |
| 1991 Q1 | 600 Thousand USD | -14.29% |
| 1991 Q4 | 600 Thousand USD | 0.0% |
| 1991 FY | 2.2 Million USD | -8.33% |
| 1991 Q3 | 600 Thousand USD | 20.0% |
| 1991 Q2 | 500 Thousand USD | -16.67% |
| 1990 FY | 2.4 Million USD | 0.0% |
| 1990 Q2 | -4.2 Million USD | -210.53% |
| 1990 Q1 | 3.8 Million USD | 80.95% |
| 1990 Q4 | 700 Thousand USD | 40.0% |
| 1990 Q3 | 500 Thousand USD | 111.9% |
| 1989 Q1 | - USD | 0.0% |
| 1989 FY | 2.4 Million USD | 9.09% |
| 1989 Q4 | 2.1 Million USD | 200.0% |
| 1989 Q3 | 700 Thousand USD | 112.28% |
| 1989 Q2 | -5.7 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1230.506% |
| Cerus Corporation | 143.15 Million USD | -4.318% |
| OrthoPediatrics Corp. | 137.01 Million USD | -8.989% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1214.477% |
| Talis Biomedical Corporation | 67.18 Million USD | -122.272% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -498.637% |
| Inogen, Inc. | 236.08 Million USD | 36.745% |
| Spectral AI, Inc. | 20.86 Million USD | -615.759% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -166.686% |
| CVRx, Inc. | 76.14 Million USD | -96.128% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -4132.885% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -1095.74% |
| Orthofix Medical Inc. | 667.42 Million USD | 77.625% |
| Venus Concept Inc. | 80.47 Million USD | -85.566% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -163.947% |
| Bioventus Inc. | 409.91 Million USD | 63.569% |
| BrainsWay Ltd. | 28.01 Million USD | -433.0% |
| Envoy Medical, Inc. | 17.89 Million USD | -734.373% |
| electroCore, Inc. | 32.03 Million USD | -366.223% |
| IceCure Medical Ltd | 16.87 Million USD | -784.902% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -251.942% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -746.911% |
| MaxCyte, Inc. | 84.84 Million USD | -76.01% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1103.181% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2483.062% |
| PAVmed Inc | 64.82 Million USD | -130.361% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -192.369% |
| RxSight, Inc. | 103.85 Million USD | -43.8% |
| Sight Sciences, Inc. | 126.44 Million USD | -18.1% |
| SI-BONE, Inc. | 156.35 Million USD | 4.487% |
| TELA Bio, Inc. | 84.18 Million USD | -77.386% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -113.167% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 26.568% |
| LivaNova PLC | 843.54 Million USD | 82.297% |
| 908 Devices Inc. | 68.08 Million USD | -119.354% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 69.12% |
| Nemaura Medical Inc. | 7.13 Million USD | -1991.891% |
| NeuroPace, Inc. | 75.29 Million USD | -98.332% |
| LENSAR, Inc. | 33.33 Million USD | -347.972% |
| Apyx Medical Corporation | 51.01 Million USD | -192.712% |
| Cutera, Inc. | 197.72 Million USD | 24.472% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -502.623% |
| BioSig Technologies, Inc. | 28.53 Million USD | -423.435% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 22.008% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -314.132% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 82.145% |
| Axonics, Inc. | 270.2 Million USD | 44.732% |
| Outset Medical, Inc. | 198.77 Million USD | 24.87% |
| IRIDEX Corporation | 31.81 Million USD | -369.403% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 17.136% |
| IRadimed Corporation | 30.12 Million USD | -395.757% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -1650.305% |
| INVO Bioscience, Inc. | 7.85 Million USD | -1801.572% |
| Telesis Bio, Inc. | 63.48 Million USD | -135.216% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -51.683% |
| Varex Imaging Corporation | 224.8 Million USD | 33.569% |
| Quipt Home Medical Corp. | 148.66 Million USD | -0.45% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1173.872% |
| Pulmonx Corporation | 112.68 Million USD | -32.523% |
| Dynatronics Corporation | 9.9 Million USD | -1407.223% |
| Modular Medical, Inc. | 17.52 Million USD | -751.937% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -639.763% |
| Semler Scientific, Inc. | 38.94 Million USD | -283.463% |
| InMode Ltd. | 215.68 Million USD | 30.76% |
| Bruker Corporation | 1.07 Billion USD | 86.126% |
| Cytosorbents Corporation | 48.33 Million USD | -208.949% |
| DexCom, Inc. | 1.69 Billion USD | 91.17% |
| Align Technology, Inc. | 2.07 Billion USD | 92.809% |
| Viveve Medical, Inc. | 22.17 Million USD | -573.504% |
| ZimVie Inc. | 275.12 Million USD | 45.721% |
| Movano Inc. | 29.69 Million USD | -402.984% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -8.789% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2483.062% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -4132.885% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 75.149% |
| Profound Medical Corp. | 33.6 Million USD | -344.411% |
| Insulet Corporation | 939.9 Million USD | 84.112% |
| enVVeno Medical Corporation | 25.23 Million USD | -491.711% |
| Surmodics, Inc. | 98.69 Million USD | -51.308% |
| iCAD, Inc. | 22.22 Million USD | -571.928% |
| Nuwellis, Inc. | 22.61 Million USD | -560.399% |
| Biotricity, Inc. | 17.18 Million USD | -769.013% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 66.508% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1116.338% |
| InspireMD, Inc. | 22.95 Million USD | -550.702% |
| PAVmed Inc. | 64.82 Million USD | -130.361% |
| BIOLASE, Inc. | 34.66 Million USD | -330.847% |
| Beyond Air, Inc. | 61.7 Million USD | -142.036% |
| FONAR Corporation | 28.6 Million USD | -422.068% |
| Vivani Medical, Inc. | 26.96 Million USD | -453.814% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 15.673% |
| Inari Medical, Inc. | 448.59 Million USD | 66.71% |
| UFP Technologies, Inc. | 58.08 Million USD | -157.081% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -2930.604% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -2263.551% |
| Tenon Medical, Inc. | 16.96 Million USD | -780.104% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -1919.965% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -238.609% |
| AdaptHealth Corp. | 1.07 Billion USD | 86.146% |
| Sintx Technologies, Inc. | 15.2 Million USD | -882.409% |
| NanoVibronix, Inc. | 4.97 Million USD | -2902.936% |
| Quanterix Corporation | 118.1 Million USD | -26.449% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1173.872% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -934.04% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 61.969% |
| TransMedics Group, Inc. | 182.82 Million USD | 18.315% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -432.108% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1245.499% |
| Hyperfine, Inc. | 52.87 Million USD | -182.448% |
| Establishment Labs Holdings Inc. | 172 Million USD | 13.178% |
| Biomerica, Inc. | 6.97 Million USD | -2040.097% |
| Bone Biologics Corporation | 9.42 Million USD | -1483.912% |
| AVITA Medical, Inc. | 80.77 Million USD | -84.869% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -1348.287% |
| Silk Road Medical, Inc | 186.35 Million USD | 19.866% |